Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Simerzin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Bioengineering and Biotechnology|April 10, 2026
Quantifying single-cell responses to irradiation in 3DJoshua François, Alina Simerzin, Ashwini Jambhekar, et al.
Science Advances|October 25, 2024
Temporal regulation of gene expression through integration of p53 dynamics and modificationsDan Lu, Marjan Faizi, Bryon Drown, et al.
Molecular Biology of the Cell|April 9, 2025
Cell confluency affects p53 dynamics in response to DNA damageAlina Simerzin, Emily E Ackerman, Kotaro Fujimaki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2010
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vectorAlbert Grinshpun, Reba Condiotti, Simon N Waddington, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryAlina Simerzin, Elina Zorde-Khvalevsky, Mila Rivkin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 29, 2013
Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signatureReba Condiotti, Daniel Goldenberg, Hilla Giladi, et al.
Gastroenterology|August 2, 2016
Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and AnemiaMila Rivkin, Alina Simerzin, Elina Zorde-Khvalevsky, et al.
Cancers|January 27, 2021
The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADDRona Harari-Steinfeld, Maytal Gefen, Alina Simerzin, et al.
Gastroenterology|August 14, 2017
Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle TissuesChofit Chai, Mila Rivkin, Liav Berkovits, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Mutant KRAS is a druggable target for pancreatic cancerElina Zorde Khvalevsky, Racheli Gabai, Itzhak Haim Rachmut, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Bioengineering and Biotechnology|April 10, 2026
Quantifying single-cell responses to irradiation in 3DJoshua François, Alina Simerzin, Ashwini Jambhekar, et al.
Science Advances|October 25, 2024
Temporal regulation of gene expression through integration of p53 dynamics and modificationsDan Lu, Marjan Faizi, Bryon Drown, et al.
Molecular Biology of the Cell|April 9, 2025
Cell confluency affects p53 dynamics in response to DNA damageAlina Simerzin, Emily E Ackerman, Kotaro Fujimaki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2010
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vectorAlbert Grinshpun, Reba Condiotti, Simon N Waddington, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryAlina Simerzin, Elina Zorde-Khvalevsky, Mila Rivkin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 29, 2013
Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signatureReba Condiotti, Daniel Goldenberg, Hilla Giladi, et al.
Gastroenterology|August 2, 2016
Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and AnemiaMila Rivkin, Alina Simerzin, Elina Zorde-Khvalevsky, et al.
Cancers|January 27, 2021
The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADDRona Harari-Steinfeld, Maytal Gefen, Alina Simerzin, et al.
Gastroenterology|August 14, 2017
Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle TissuesChofit Chai, Mila Rivkin, Liav Berkovits, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Mutant KRAS is a druggable target for pancreatic cancerElina Zorde Khvalevsky, Racheli Gabai, Itzhak Haim Rachmut, et al.
Pageof 2